Search Result "Doxorubicin-DNA adduct"
Potential Therapeutic Advantages of Doxorubicin when Activated by Formaldehyde to Function as a DNA Adduct-Forming Agent
Journal: Current Topics in Medicinal Chemistry
Volume: 15 Issue: 14 Year: 2015 Page: 1409-1422
Author(s): Suzanne M. Cutts,Ada Rephaeli,Abraham Nudelman,Michal Ugarenko,Don R. Phillips
Endogenous Glutathione Adducts
Journal: Current Drug Metabolism
Volume: 7 Issue: 8 Year: 2006 Page: 853-872
Author(s): Ian A. Blair
Barminomycin, a Model for the Development of New Anthracyclines
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2010 Page: 70-77
Author(s): K. Kimura, D. M.S. Spencer, R. Bilardi, L. P. Swift, A. J. Box, R. T.C. Brownlee, S. M. Cutts, D. R. Phillips
DNA-drug Conjugates for Site-specific Delivery in Anti-cancer Therapy
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 14 Issue: 2 Year: 2016 Page: 68-73
Author(s): Karimpanakkal C. Ajithkumar,Kannissery Pramod
Recent Advances in Understanding and Exploiting the Activation of Anthracyclines by Formaldehyde
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 5 Issue: 5 Year: 2005 Page: 431-447
Author(s): S. M. Cutts, L. P. Swift, A. Rephaeli, A. Nudelman, D. R. Phillips
Antimitotic Activity on Sea Urchin Embryonic Cells of Seven Antiparasitic Morita-Baylis-Hillman Adducts: A Potential New Class of Anticancer Drugs
Journal: Medicinal Chemistry
Volume: 8 Issue: 6 Year: 2012 Page: 1003-1011
Author(s): Jocelmo C. A. Leite, Claudio G. L. Junior, Fabio P. L. Silva, Suervy C.O. Sousa, Mario L. A. A. Vasconcellos, Luis F. Marques-Santos
Non-B DNA Structures as Candidate Drug Targets Against Structural Chromosomal Instability
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 16 Issue: 2 Year: 2018 Page: 94-107
Author(s): Nevim Aygun
Nuclear Targeting and Retention of Anthracycline Antitumor Drugs in Sensitive and Resistant Tumor Cells
Journal: Current Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2001 Page: 15-29
Author(s): Dylan J. Taatjes, Tad H. Koch
Cisplatin Analogues with an Increased Interaction with DNA: Prospects for Therapy
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 44 Year: 2016 Page: 6645-6664
Author(s): Megan E. Hardie,Hieronimus W. Kava,Vincent Murray
Mechanisms of Action of DNA-Damaging Anticancer Drugs in Treatment of Carcinomas: Is Acute Apoptosis an “Off-Target” Effect?
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 1035-1039
Author(s): Aleksandra Mandic Havelka, Maria Berndtsson, Maria Hagg Olofsson, Maria C. Shoshan, Stig Linder